Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(25%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph early_phase_1
1
13%
Ph phase_2
2
25%
Ph phase_4
2
25%
Ph not_applicable
3
38%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 42 (25.0%)
N/A3 (37.5%)

Trials by Status

not_yet_recruiting113%
completed450%
recruiting225%
terminated113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8